Rechallenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy

被引:0
|
作者
Guo, X.
Loibl, S.
Untch, M.
Moebus, V.
Schwedler, K.
Fasching, P. A.
Barinoff, J.
Holms, F.
Thomssen, C.
Zahm, D. M.
Kreienberg, R.
Hauschild, M.
Eidtmann, H.
Tauchert, S.
Mehta, K.
Von Minckwitz, G.
机构
[1] German Breast Grp, Neu Isenburg, Germany
[2] Helios Klinikum Berlin Buch, Berlin, Germany
[3] Klinikum Frankfurt Hochst, Frauenklin, Frankfurt, Germany
[4] Univ Frauenklin Frankfurt, Frankfurt, Germany
[5] Univ Klinikum Erlangen, Frauenklin, Erlangen, Germany
[6] Klinken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany
[7] Barbaraklin, Hamm, Germany
[8] Martin Luther Univ Halle Saale, Halle, Germany
[9] Frauenklin Gera, Gera, Germany
[10] Univ Ulm, Dept Gynecol & Obstet, D-89069 Ulm, Germany
[11] Frauenklin Rheinfelden, Rheinfelden, Germany
[12] Univ Schleswig Holstein, Kiel, Germany
[13] Uni Frauenklin Kiel, Kiel, Germany
关键词
D O I
10.1200/jco.2011.29.15_suppl.1055
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1055
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
    Guo, Xinrong
    Loibl, Sibylle
    Untch, Michael
    Moebus, Volker
    Schwedler, Kathrin
    Fasching, Peter A.
    Barinoff, Jana
    Holms, Frank
    Thomssen, Christoph
    Zahm, Dirk M.
    Kreienberg, Rolf
    Hauschild, Maik
    Eidtmann, Holger
    Tauchert, Sascha
    Mehta, Keyur
    von Minckwitz, Gunter
    BREAST CARE, 2011, 6 (04) : 279 - 283
  • [2] Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes
    Kucukoztas, Nadire
    Oguz, Arzu
    Rahatli, Samed
    Altundag, Ozden
    Altundag, Kadri
    JOURNAL OF BUON, 2016, 21 (05): : 1076 - 1081
  • [3] Taxane-based therapy for breast cancer: Combination or sequential therapy?
    Sparano, JA
    Rajdev, L
    CANCER INVESTIGATION, 2000, 18 (05) : 498 - 500
  • [4] The molecular characterisation of early and advanced breast cancer in a Middle-Eastern breast cancer cohort treated with neo/adjuvant anthracycline plus /-taxane-based chemotherapy
    Dawood, S.
    Korbie, D.
    Pheasant, M.
    Kazim, H.
    Al Hamadi, A.
    Lloyd, C.
    Dent, R.
    Mainwaring, P. N.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] The role of (neo-)adjuvant therapy in rectal cancer
    Ulrich, A
    Hartel, M
    Weitz, J
    Friess, H
    Büchler, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (17) : 957 - 962
  • [6] Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.
    Oguz, Arzu
    Babacan, Taner
    Dizdar, Omer
    Kucukoztas, Nadire
    Rahatli, Samed
    Keskin, Gul Sema Yildiran
    Altundag, Ozden
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Colitis in patients with breast carcinoma treated with taxane-based chemotherapy
    Li, ZY
    Ibrahim, NK
    Wathen, JK
    Wang, M
    Menchu, RPM
    Valero, V
    Theriault, R
    Buzdar, AU
    Hortobagyi, GN
    CANCER, 2004, 101 (07) : 1508 - 1513
  • [8] Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients
    Alacacioglu, Ahmet
    Zengel, Baha
    Denecli, Ali Galip
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2009, 4 (04): : 454 - 458
  • [9] Toxicity in elderly breast cancer patients treated by a taxane based chemotherapy as adjuvant or neoadjuvant therapy for primary breast cancer
    Loibl, S.
    von Minckwitz, G.
    Elling, D.
    Janni, W.
    Kaufmann, M.
    Vescia, S.
    Eggemann, H.
    Harbeck, N.
    Nekljudova, V.
    Kuemmel, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 158 - 158
  • [10] Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
    Liao, Yuqian
    Liao, Yulu
    Li, Jun
    Li, Junyu
    Fan, Ying
    Xu, Binghe
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3801 - 3808